Chris Blanchette
In this exclusive interview, Chris Blanchette, Vice President of Clinical Data Science & Evidence at Novo Nordisk, explores how AI, advanced analytics, and evolving healthcare expectations are transforming evidence generation across the pharmaceutical industry.
In this conversation, Chris shares insights on:
- Why demand for real-world evidence is accelerating
- The impact of AI on evidence generation and decision-making
- Balancing innovation with trust, transparency, and credibility
- Building enterprise evidence systems that deliver decision-grade insights
- How patient expectations and consumer-driven healthcare are reshaping the industry
- The capabilities future evidence leaders will need to succeed